Zynerba Press Releases

24 May 22 Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

17 May 22 Zynerba Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

16 May 22 Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights

11 May 22 Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel™ in Children and Adolescents with Fragile X Syndrome (FXS) at the International Society for Autism Research Annual Meeting

9 May 22 Zynerba Pharmaceuticals Announces Podium Presentation at the International Society for Autism Research Annual Meeting

2 May 22 Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel™ in Children and Adolescents with Fragile X Syndrome (FXS) at the 2022 Society of Biological Psychiatry Annual Meeting

21 Apr 22 Zynerba Pharmaceuticals Announces Presentation of Poster at the 2022 Society of Biological Psychiatry Annual Meeting

5 Apr 22 Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference

22 Mar 22 Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit

1 Mar 22 Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights